These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34021680)

  • 21. Prevalence and risk factors of renal tubular acidosis after kidney transplantation.
    Malik SI; Naqvi R; Ahmed E; Zafar MN
    J Pak Med Assoc; 2011 Jan; 61(1):23-7. PubMed ID: 22368897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose-insulin infusion for the early treatment of non-oliguric hyperkalemia in extremely-low-birth-weight infants.
    Hung KC; Su BH; Lin TW; Peng CT; Tsai CH
    Acta Paediatr Taiwan; 2001; 42(5):282-6. PubMed ID: 11729704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of hyperkalemia in hospitalized patients.
    Fordjour KN; Walton T; Doran JJ
    Am J Med Sci; 2014 Feb; 347(2):93-100. PubMed ID: 23255245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of fludrocortisone in the management of tacrolimus-induced hyperkalemia in a renal transplant recipient.
    Sivakumar V; Sriramnaveen P; Krishna C; Manjusha Y; Reddy YS; Sridhar N; Subramanian S
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):149-51. PubMed ID: 24434399
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate.
    Lee J; Moffett BS
    Pediatr Nephrol; 2016 Nov; 31(11):2113-7. PubMed ID: 27215929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The optimal dose of potassium citrate in the treatment of children with distal renal tubular acidosis.
    Tapaneya-Olarn W; Khositseth S; Tapaneya-Olarn C; Teerakarnjana N; Chaichanajarernkul U; Stitchantrakul W; Petchthong T
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1143-9. PubMed ID: 12549788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Patiromer in Hyperkalemic Patients Taking and Not Taking RAAS Inhibitors.
    Kloner RA; Gross C; Yuan J; Conrad A; Pergola PE
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):524-531. PubMed ID: 30103622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical spectrum of renal tubular acidosis.
    Rocher LL; Tannen RL
    Annu Rev Med; 1986; 37():319-31. PubMed ID: 3518609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Sodium Polystyrene Sulfonate Dosing Strategies in the Inpatient Management of Hyperkalemia.
    Mistry M; Shea A; Giguère P; Nguyen ML
    Ann Pharmacother; 2016 Jun; 50(6):455-62. PubMed ID: 27048188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal tubular acidosis in renal transplant patients: the effect of immunosuppressive drugs.
    Tanrisev M; Gungor O; Kocyigit I; Kurtulmus Y; Tugmen C; Colak H; Altunoren O; Kebapci E; Karaca C
    Ann Transplant; 2015 Feb; 20():85-91. PubMed ID: 25659354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contralateral suppression of aldosterone at adrenal venous sampling predicts hyperkalemia following adrenalectomy for primary aldosteronism.
    Shariq OA; Bancos I; Cronin PA; Farley DR; Richards ML; Thompson GB; Young WF; McKenzie TJ
    Surgery; 2018 Jan; 163(1):183-190. PubMed ID: 29129366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating interdialytic hyperkalemia with fludrocortisone.
    Imbriano LJ; Durham JH; Maesaka JK
    Semin Dial; 2003; 16(1):5-7. PubMed ID: 12535291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fludrocortisone therapy in renal transplant recipients with persistent hyperkalemia.
    Marfo K; Glicklich D
    Case Rep Transplant; 2012; 2012():586859. PubMed ID: 23259135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of failure to thrive: diagnostic yield of testing for renal tubular acidosis.
    Adedoyin O; Gottlieb B; Frank R; Vento S; Vergara M; Gauthier B; Trachtman H
    Pediatrics; 2003 Dec; 112(6 Pt 1):e463. PubMed ID: 14654646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperkalemia in both surgically and medically treated patients with primary aldosteronism.
    Wada N; Shibayama Y; Umakoshi H; Ichijo T; Fujii Y; Kamemura K; Kai T; Sakamoto R; Ogo A; Matsuda Y; Fukuoka T; Tsuiki M; Suzuki T; Naruse M
    J Hum Hypertens; 2017 Oct; 31(10):627-632. PubMed ID: 28540931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of hyperkalemia with fludrocortisone in a patient with systemic lupus erythematosus.
    Dreyling KW; Wanner C; Schollmeyer P
    Clin Nephrol; 1990 Apr; 33(4):179-83. PubMed ID: 2350905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete renal tubular acidosis late after kidney transplantation.
    Schwarz C; Benesch T; Kodras K; Oberbauer R; Haas M
    Nephrol Dial Transplant; 2006 Sep; 21(9):2615-20. PubMed ID: 16644772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early initiation of angiotensin-converting enzyme inhibitors in postrenal transplant period: A study from a state-run tertiary care center.
    Sreeadhara CG; Narayanaswamy R; Lingaraju U; Leelavathi V; Shivaprasad SM
    Saudi J Kidney Dis Transpl; 2018; 29(3):637-642. PubMed ID: 29970741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Type IV renal tubular acidosis: pathogenetic role of aldosterone deficiency and hyperkalemia].
    Schambelan M; Sebastian A
    Nephrologie; 1985; 6(3):135-7. PubMed ID: 3908957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The frequency of hyperkalemia and its significance in chronic kidney disease.
    Einhorn LM; Zhan M; Hsu VD; Walker LD; Moen MF; Seliger SL; Weir MR; Fink JC
    Arch Intern Med; 2009 Jun; 169(12):1156-62. PubMed ID: 19546417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.